Injectable Treatments Kybella for Double Chins
Kybella Double Chin Treatment
New Non-Surgical Injectable Procedure Destroys Fat Cells Beneath the Chin
Is your "double chin" getting in the way of a good selfie? Double chins are a very common condition that affects both men and women. Stubborn fat beneath the chin is often resistant to diet and exercise alone.
KYBELLA® is the first and only FDA-approved injectable treatment used in adults to improve the appearance of moderate to severe fat below the chin, also called "submental fat." Treatments with Kybella at Hedden Plastic Surgery destroy the fat cells that create a double chin to give your lower face, chin and neck a more youthful and contoured profile.
Kybella's active ingredient is deoxycholic acid, which is naturally produced by the body and helps you absorb fat. Fat cleared from the treatment area is processed through the body's natural metabolism.
Submental Fullness, or the ‘Double Chin’
A broad range of adults are affected by submental fullness, or the appearance of a double chin. Submental fullness is influenced by aging, weight gain and genetic predisposition. Chin fat can be very difficult to get rid of on your own, even for people who eat well and get regular exercise.
A 2015 survey conducted by the American Society for Dermatologic Surgery found that aesthetically-oriented consumers were as concerned with excess under-the-chin fat as they were with lines and wrinkles around the eyes.
Kybella Chin Fat Treatments in Birmingham, Alabama
Kybella improves the appearance of fat below the chin by physically destroying fat cells in the submental area beneath the skin. Once these stubborn fat cells are destroyed, they can no longer store or accumulate fat.
Non-surgical Kybella treatments at Hedden Plastic Surgery are performed during an office visit to our Birmingham, Alabama cosmetic center. During treatment sessions, which may take from 15 to 20 minutes, Kybella is delivered into the fat below your chin with a series of injections from a tiny needle. The injection destroys the membranes of the fat cells, after which the fat is naturally processed by the body.
During your complimentary consultation at Hedden Plastic Surgery, a customized treatment plan is created based on the amount and distribution of your submental fat and your personal treatment goals. Many patients see visible results with two to four Kybella treatments, while up to six treatments may be administered at least 1 month apart.
Retreatment is not expected once you have achieved your desired aesthetic result. In clinical studies, 79% of people treated with Kybella had improved satisfaction with the appearance of the area beneath their chin 12 weeks after their last treatment.
Following treatment with Kybella, you are likely to have some swelling. Ice or a cold pack will be applied to the treatment area for 10 to 15 minutes, as needed. Downtime was found to occur most commonly after the first treatment session.
Non-Invasive Chin Fat Reduction
Until recently, people who considered cosmetic surgery to reduce under-the-chin fat were left to choose between surgical procedures such as neck liposuction or a neck lift. Now, Kybella Double Chin treatment and the CoolSculpting CoolMini are available for non-invasive fat reduction in the submental area beneath the chin.
Kybella Important Safety Information
KYBELLA® (deoxycholic acid) injection 10 mg/mL
Indication and Important Safety Information
KYBELLA® (deoxycholic acid) injection is indicated for improvement in the appearance of moderate to severe convexity or fullness associated with submental fat in adults.
The safe and effective use of KYBELLA® for the treatment of subcutaneous fat outside the submental region has not been established and is not recommended.
KYBELLA® is contraindicated in the presence of infection at the injection sites.
Warnings and Precautions
Marginal Mandibular Nerve Injury
Cases of marginal mandibular nerve injury, manifested as an asymmetric smile or facial muscle weakness, were reported in 4% of subjects in the clinical trials; all cases resolved spontaneously (range 1-298 days, median 44 days). KYBELLA® should not be injected into or in close proximity to the marginal mandibular branch of the facial nerve.
Dysphagia occurred in 2% of subjects in the clinical trials in the setting of administration-site reactions, eg, pain, swelling, and induration of the submental area; all cases of dysphagia resolved spontaneously (range 1-81 days, median 3 days). Avoid use of KYBELLA® in patients with current or prior history of dysphagia as treatment may exacerbate the condition.
In clinical trials, 72% of subjects treated with KYBELLA® experienced hematoma/bruising. KYBELLA® should be used with caution in patients with bleeding abnormalities or who are currently being treated with antiplatelet or anticoagulant therapy as excessive bleeding or bruising in the treatment area may occur.
Risk of Injecting Into or in Proximity to Vulnerable Anatomic Structures
To avoid the potential of tissue damage, KYBELLA® should not be injected into or in close proximity (1 cm-1.5 cm) to salivary glands, lymph nodes, and muscles.
The most commonly reported adverse reactions in the pivotal clinical trials were: injection site edema/swelling, hematoma/bruising, pain, numbness, erythema, and induration.
- Allure Best of Beauty Breakthrough Award 2015 recipient
- featured in Harper's Bazaar, Allure, Elle, People & on the Today Show
Please contact our Alabama cosmetic surgeons today to learn more about getting rid of excess fat below the chin with non-surgical Kybella injectable treatments.